BioPharma Credit PLC (FRA:B3P)

BioPharma Credit Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	874	1,014	990	1,173	1,169	1,119
Market Cap Growth	-10.17%	2.39%	-15.58%	0.28%	4.54%	-10.42%
Enterprise Value	871	978	929	1,163	1,062	1,069
Last Close Price	0.78	0.68	0.59	0.60	0.51	-
PE Ratio	8.34	8.59	10.09	6.87	15.65	15.35
PS Ratio	6.64	7.00	8.06	5.74	12.80	12.44
PB Ratio	0.89	0.89	0.82	0.94	0.98	0.99
P/TBV Ratio	0.89	0.89	0.82	0.94	0.98	0.99
P/OCF Ratio	10.47	9.38	8.88	6.80	13.79	23.56
EV/Sales Ratio	6.54	6.75	7.56	5.70	11.62	11.88
EV/EBIT Ratio	8.22	8.29	9.46	6.82	14.21	14.67
Asset Turnover	0.13	0.12	0.10	0.16	0.08	0.08
Quick Ratio	7.87	2.09	9.79	5.34	16.51	20.60
Current Ratio	7.87	2.09	9.79	5.34	16.51	20.60
Return on Equity (ROE)	10.35%	9.69%	8.10%	13.50%	6.19%	6.41%
Return on Assets (ROA)	6.44%	5.97%	4.98%	8.33%	3.85%	3.96%
Return on Capital (ROIC)	6.47%	6.05%	5.06%	8.44%	3.87%	4.00%
Return on Capital Employed (ROCE)	10.70%	10.30%	8.10%	13.60%	6.20%	6.50%
Earnings Yield	11.99%	11.64%	9.91%	14.55%	6.39%	6.51%
Dividend Yield	11.18%	10.01%	10.79%	10.85%	12.06%	-
Payout Ratio	46.01%	89.23%	63.58%	52.52%	113.20%	107.90%
Buyback Yield / Dilution	7.85%	6.65%	4.00%	0.72%	0.00%	0.00%
Total Shareholder Return	19.02%	16.66%	14.79%	11.57%	12.06%	0.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.